The researchers concluded that the alterations in the expression of DVL1, DVL3, E-cadherin, and β-catenin in brain metastases underscore the importance of the Wnt signaling pathway in the metastatic process of lung cancer to the brain, providing valuable insights into potential therapeutic targets for intervention. The gene discussed is DVL3; the disease is lung carcinoma.